Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 9001-9050 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05416996
A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer
N/A
Active, not recruiting
88 participants
Started: Jun 5, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06386042
Guideline Implementation and Quality of Care in Patients With Heart Failure: the TITRATE-HF Registry
N/A
Active, not recruiting
4,289 participants
Started: Jun 5, 2022 · Completed: Apr 30, 2029
1 condition
2 sponsors
1 location
NCT05244213
Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC
PHASE2
Active, not recruiting
35 participants
Started: Jun 4, 2022 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT05408936
SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers
N/A
Active, not recruiting
80 participants
Started: Jun 3, 2022 · Completed: Jun 1, 2024
1 condition
1 sponsor
1 location
NCT05412212
Brief Educational Video for Patients Prescribed LTBI Treatment
NA
Active, not recruiting
1,898 participants
Started: Jun 3, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05056896
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
EARLY_PHASE1
Active, not recruiting
161 participants
Started: Jun 3, 2022 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT05092958
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
PHASE3
Active, not recruiting
654 participants
Started: Jun 3, 2022 · Completed: Dec 10, 2025
18 conditions
1 sponsor
276 locations
NCT05392608
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
PHASE2
Active, not recruiting
130 participants
Started: Jun 2, 2022 · Completed: Mar 31, 2028
2 conditions
3 sponsors
25 locations
NCT05243862
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
PHASE2
Active, not recruiting
18 participants
Started: Jun 2, 2022 · Completed: Jun 2, 2026
1 condition
3 sponsors
3 locations
NCT05195632
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
63 participants
Started: Jun 2, 2022 · Completed: Sep 5, 2026
1 condition
1 sponsor
34 locations
NCT05282485
Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides
NA
Active, not recruiting
140 participants
Started: Jun 2, 2022 · Completed: Sep 10, 2027
3 conditions
5 sponsors
1 location
NCT05417906
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
PHASE2
Active, not recruiting
110 participants
Started: Jun 2, 2022 · Completed: Sep 30, 2026
2 conditions
2 sponsors
2 locations
NCT06158789
Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.
NA
Active, not recruiting
6 participants
Started: Jun 2, 2022 · Completed: Jan 19, 2024
1 condition
2 sponsors
1 location
NCT03856515
Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes
NA
Active, not recruiting
169 participants
Started: Jun 2, 2022 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT05409261
Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine
PHASE2
Active, not recruiting
200 participants
Started: Jun 2, 2022 · Completed: Mar 31, 2025
4 conditions
6 sponsors
1 location
NCT05115110
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
PHASE2/PHASE3
Active, not recruiting
259 participants
Started: Jun 2, 2022 · Completed: Feb 27, 2029
1 condition
1 sponsor
35 locations
NCT05428969
A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
PHASE1/PHASE2
Active, not recruiting
181 participants
Started: Jun 2, 2022 · Completed: Apr 30, 2026
4 conditions
1 sponsor
10 locations
NCT05991167
"EndeavorRx® Prospective Product Registry (Expedition EndeavorRx)"
N/A
Active, not recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06177210
Type 2 Diabetes Remission
N/A
Active, not recruiting
20 participants
Started: Jun 1, 2022 · Completed: Aug 30, 2025
1 condition
2 sponsors
1 location
NCT04808206
A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy
N/A
Active, not recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
3 locations
NCT05062915
Diagnostic Work up and Management of Acute Onset Vertigo
NA
Active, not recruiting
90 participants
Started: Jun 1, 2022 · Completed: Jul 1, 2025
2 conditions
1 sponsor
1 location
NCT06633094
Home Management of Pediatric Buckle Fractures
NA
Active, not recruiting
46 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT03935997
Implementing, Evaluating, and Scaling Up of the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) Program
NA
Active, not recruiting
594 participants
Started: Jun 1, 2022 · Completed: Jan 31, 2026
1 condition
7 sponsors
4 locations
NCT06499337
Safety Plan in Emergency Department to Prevent Suicidal Attempt Recidive
N/A
Active, not recruiting
80 participants
Started: Jun 1, 2022 · Completed: Jul 31, 2024
4 conditions
1 sponsor
1 location
NCT06240169
Effect of Age on the Success of DPC Using Bio-ceramic Materials in Cariously Exposed Teeth With Reversible Pulpitis
NA
Active, not recruiting
174 participants
Started: Jun 1, 2022 · Completed: Mar 30, 2024
1 condition
1 sponsor
1 location
NCT06647719
Postoperative Care After Carpal Tunnel Release Using Short Educational Videos
NA
Active, not recruiting
84 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT05795400
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
NA
Active, not recruiting
50 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2025
4 conditions
1 sponsor
1 location
NCT04739995
Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia
PHASE4
Active, not recruiting
99 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT05366712
Nexus Evaluation Primary Trident II Uncemented Shell
NA
Active, not recruiting
125 participants
Started: Jun 1, 2022 · Completed: Nov 25, 2034
4 conditions
2 sponsors
1 location
NCT05220631
Digital Nutrition Intervention for Older Adults
NA
Active, not recruiting
369 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2025
3 conditions
5 sponsors
1 location
NCT05448092
Registry for Evaluation of Lumbar Arthrodesis Sagittal alignmEnt
N/A
Active, not recruiting
500 participants
Started: Jun 1, 2022 · Completed: Jun 26, 2025
3 conditions
19 sponsors
8 locations
NCT06283017
Evaluation of the Effects of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea
NA
Active, not recruiting
14 participants
Started: Jun 1, 2022 · Completed: Mar 31, 2024
4 conditions
2 sponsors
1 location
NCT05375903
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
PHASE1
Active, not recruiting
51 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
6 conditions
1 sponsor
13 locations
NCT05564247
Wheelchair Skills Training for Children and Youth
NA
Active, not recruiting
60 participants
Started: Jun 1, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
3 locations
NCT06457698
Temporomandibular Bioviscosuplementation (Platelet-Rich Plasma Combined With Hyaluronic Acid) After Double-Puncture Arthrocentesis: a Randomized Controlled Trial
NA
Active, not recruiting
50 participants
Started: Jun 1, 2022 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT06091137
Appendectomy and Colorectal Cancer
N/A
Active, not recruiting
180,000 participants
Started: Jun 1, 2022 · Completed: May 31, 2025
2 conditions
1 sponsor
1 location
NCT05558436
Comparison of Diagnostic Sensitivity Between ctDNA Methylation and CEA in Colorectal Cancer
N/A
Active, not recruiting
662 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05368350
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
NA
Active, not recruiting
12 participants
Started: Jun 1, 2022 · Completed: Apr 16, 2026
2 conditions
1 sponsor
1 location
NCT05248477
Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX)
NA
Active, not recruiting
2,377 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05318573
A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
120 participants
Started: Jun 1, 2022 · Completed: Nov 30, 2029
2 conditions
2 sponsors
23 locations
NCT05385692
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors
PHASE1
Active, not recruiting
22 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT06670989
Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision Loss
NA
Active, not recruiting
30 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05818449
Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)
NA
Active, not recruiting
850 participants
Started: Jun 1, 2022 · Completed: Mar 31, 2025
1 condition
16 sponsors
41 locations
NCT07127497
Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
PHASE2
Active, not recruiting
50 participants
Started: Jun 1, 2022 · Completed: Oct 1, 2028
1 condition
1 sponsor
1 location
NCT05365776
Graded Exposure Therapy for Fear Avoidance Behaviour After Concussion
NA
Active, not recruiting
220 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
7 locations
NCT05365711
Carriage of Beta Haemolytic Streptococci During Pregnancy
N/A
Active, not recruiting
1,040 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05323721
Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda
PHASE4
Active, not recruiting
6,805 participants
Started: Jun 1, 2022 · Completed: Dec 1, 2023
1 condition
1 sponsor
1 location
NCT05329025
A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
100 participants
Started: Jun 1, 2022 · Completed: Jan 1, 2024
1 condition
1 sponsor
1 location
NCT05394675
A Study of DS-9606a in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
88 participants
Started: May 31, 2022 · Completed: Feb 19, 2026
4 conditions
1 sponsor
7 locations
NCT05355298
ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
PHASE1/PHASE2
Active, not recruiting
62 participants
Started: May 31, 2022 · Completed: May 1, 2026
3 conditions
1 sponsor
13 locations
Previous
1
More pages
178
179
180
181
182
183
184
More pages
431
Next